Plasma S-Adenosylmethionine is Associated with Lung Injury in COVID-19

  1. Evgeny Kryukov
  2. Alexander Ivanov
  3. Vladimir Karpov
  4. Valery Alexandrin
  5. Alexander Dygai
  6. Maria Kruglova
  7. Gennady Kostiuchenko
  8. Sergei Kazakov
  9. Aslan Kubatiev
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

Objective

S-Adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) are indicators of global transmethylation and may play an important role as markers of severity of COVID-19.

Methods

The levels of plasma SAM and SAH were determined in patients admitted with COVID-19 (n = 56, mean age = 61). Lung injury was identified by computed tomography (CT) in accordance with the CT0-4 classification.

Results

SAM was found to be a potential marker of lung damage risk in COVID-19 patients (SAM > 80 nM; CT3,4 vs. CT 0-2: relative ratio (RR) was 3.0; p = 0.0029). SAM/SAH > 6.0 was also found to be a marker of lung injury (CT2-4 vs. CT0,1: RR = 3.47, p = 0.0004). Interleukin-6 (IL-6) levels were associated with SAM (ρ = 0.44, p = 0.01) and SAH (ρ = 0.534, p = 0.001) levels.

Conclusions

High SAM levels and high methylation index are associated with the risk of lung injury in COVID-19 patients. The association of SAM and SAH with IL-6 indicates an important role of transmethylation in the development of cytokine imbalance in COVID-19 cases.

Related articles

Related articles are currently not available for this article.